CLINICAL_TRIALS
trial_result
· 2011-01-17
Clinical Trial Update: Cetrorelix Pamoate in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH) [Phase 3]
Summary
This Phase 3 trial of cetrorelix pamoate for symptomatic benign prostatic hyperplasia has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AEterna Zentaris | Conditions: Benign Prostatic Hypertrophy | Phase 3 | Status: COMPLETED | Results posted: 2011-01-17